Novocure is a global oncology company working to extend survival in some of the most aggressive forms of cancer through the development and commercialization of its innovative therapy, Tumor Treating Fields (TTFields). Novocure’s commercialized products are approved in the United States for the treatment of adult patients with glioblastoma and malignant pleural mesothelioma.